The utility of artificial intelligence in ophthalmic clinical trials
Given the key role of clinical trials in the advancement of ophthalmic clinical practice, trialists should consider the potential for artificial intelligence-powered tools to enhance the design, recruitment, and delivery of future studies.
Authors
- Ashley Kras (ORCID: https://orcid.org/0000-0003-1160-104X)
- Siddharth Nath (ORCID: https://orcid.org/0000-0003-4520-7163)
- Edward Korot (ORCID: https://orcid.org/0000-0002-5687-1564)
- Ehsan Rahimy (ORCID: https://orcid.org/0000-0001-8446-7078)
Institutions
- The University of Sydney (AU)
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Johns Hopkins University (US)
- Moorfields Eye Hospital (GB)
- Retina Specialists of Michigan (US)
- University College London (GB)
- McGill University (CA)
- Smith-Kettlewell Eye Research Institute (US)
- Stanford University (US)
Publication Details
- Journal
- Current Opinion in Ophthalmology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1097/icu.0000000000001172
- Primary Topic
- Retinal Imaging and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00